|
Trends & Opportunities in the Arthroscopy and Soft Tissue Repair Markets
·
230 pages ·
50 Exhibits ·
41 Company Profiles ·
Pub. Date September 30, 2002 ·
Report # M401
This
report examines the state of technology and market development in arthroscopy
and soft tissue repair, with 5 and 10 year market projections. Detailed data is
provided on disease and injury states; occurrence rates; soft tissue disease
therapy trends; arthrosopic procedures by joint, mature, growth and emerging
products and technologies; market dynamics, market sizes, market growth rates
and market shares; company profiles of market leaders and emerging technology
companies. The soft tissue repair market is in rapid flux as new technologies
in the orthobiologic space emerge. In just a few years, these technologies are
expected to represent half of the all revenues derived in this market.
Executive Summary
Overview of the
U.S. Orthopedic Market
Overview of the
Soft Tissue Repair Market Segment
Clinical Trends
Surgeon’s
Perspective
Palliative
Therapies
Reparative
Therapies
Restorative
Procedures
Arthroscopic
Application by Joint
Arthroscopy of
the Knee
Arthroscopy of
the Shoulder
Arthroscopy of
the Elbow
Arthroscopy of
the Ankle
Arthroscopy of
the Wrist Joint
Arthroscopy of
Temporomandibular joint
Arthroscopy for
Foreign Body Removal
Market Leaders
Opportunities
Section 1:
Clinical Market
1.1 Disease &
Injury Types
1.1.1
Arthropathies
1.1.1.1
Arthritis
1.1.1.1.1
Demographics
of Arthritis
1.1.1.1.2
Rheumatoid
Arthritis
1.1.1.1.3
Osteoarthritis
(OA)
1.1.1.1.4
Secondary OA
1.1.1.2
Osteochondritis Dissecans (OCD)
1.1.2
Soft Tissue Disorders
1.1.2.1
Joint Derangement
1.1.2.1.1
Knee
Disclocation
1.1.2.1.2
Shoulder
Dislocations
1.1.2.1.3
Meniscal Tears
1.1.2.1.4
Rotator Cuff
Syndrome
1.1.2.1.5
Sprains &
Strains
1.1.2.2
Enthesopathies
1.1.2.2.1
Ligament
Injuries
1.1.2.2.2
Tendon
Ruptures
1.1.2.2.3
Tendinitis
1.1.2.2.4
Bursitis
1.1.2.2.5
Epicondylitis
1.2 Diagnosis
& Treatment Trends
1.2.1
Palliative Therapies
1.2.1.1
Diagnostic Arthroscopy
1.2.1.2
Arthroscopic Debridement & Lavage
1.2.1.3
Viscosupplementation
1.2.1.4
Chondroprotective Agents
1.2.2
Reparative Therapies
1.2.2.1
Arthroscopic Marrow Stimulating Techniques
1.2.2.2
Arthroscopic Repair
1.2.2.2.1
Knee
Arthroscopy
1.2.2.2.2
Shoulder
Arthroscopy
1.2.2.2.3
Other Joints
1.2.2.2.4
Tissue
Grafting
1.2.2.2.5
MIS
Arthroplasty
1.2.3
Restorative Therapies
1.2.3.1
Osteochondral Transplant Grafting
1.2.3.2
Mosaicplasty
Section 2:
Products & Technologies
2.1
Visualization Equipment
2.2 Energy
Systems
2.2.1 RF
Systems
2.2.2
Utrasonic Energy
2.2.3
Low Level Lasers
2.3 Powered
Equipment
2.4 Manual
Instruments
2.5
Mechanical Implant Systems
2.5.1
Interference Screws
2.5.2
Anchors
2.5.3
Arrows, Darts and Staples
2.5.4
MIS Unicompartmental Implants
2.6 Tissue
Implants
2.6.1
Allogenic Transplantation
2.6.2
Artificial Grafts
2.7 Emerging
Technologies
2.7.1
Synthetic Materials
2.7.1.1
Resorbables
2.7.1.2
Synthetic Resurfacing
2.7.1.3
Hydrogels
2.7.1.4
Polymer Scaffolds
2.7.2
Biological Therapies
2.7.2.1
Growth Factors & Morphogenic Proteins
2.7.2.2
Cellular Therapies
2.7.2.2.1
Mesenchymal
Stem Cells
2.7.2.2.2
Chondrocyte
Applications
2.7.2.3
Chondroprotective Agents
2.7.2.4
Tissue Engineering
2.7.2.4.1
Ex-Vivo
Engineering
2.7.2.4.2
In-Vivo
Regeneration
2.7.3
Viscoelastics
2.7.3.1
Hyaluronan-based Technologies
2.7.3.2
Other Joint Lubricants
2.7.4
OrthoPharmaceuticals
2.7.4.1
Investigational New Drugs (INDs)
Section 3:
Market
3.1 Market
Forces
3.2 Market
Size
3.3 Product
Segmentation
3.3.1
Mature Technologies
3.3.2
Growth Technologies
3.3.3
Emerging Technologies
3.4 Market
Shares
Section 4:
Company Profiles
4.1 Key
Market Leaders
4.1.1 Smith + Nephew
4.1.2
Conmed
4.1.3
Stryker
4.1.4
Johnson & Johnson
4.1.5
Genzyme Biosurgery
4.1.6
Fidia
4.1.7
Arthrex
4.1.8
Biomet
4.1.9
Arthrocare
4.1.10
Bionx Implants, Inc.
4.2
Highlighted Development Companies
4.2.1
Aastrom Biosciences
4.2.2
Acculaser Inc.
4.2.3
Advanced Tissue Sciences
4.2.4
Anika Therapeutics, Inc.
4.2.5
Artecel Sciences, Inc.
4.2.6
Articular Engineering, LLC
4.2.7
Axya Medical, Inc.
4.2.8 BD
Biosciences
4.2.9
BioDelivery Systems
4.2.10
BioTissue Technologies
4.2.11
Collagen Matrix
4.2.12
CryoLife, Inc
4.2.13
Hydrocision
4.2.14
Integra LifeSciences
4.2.15
IsoTis N.V.
4.2.16
LifeCell
4.2.17
LifeNet
4.2.18
MorphoGen Pharmaceuticals, Inc.
4.2.19
NeuColl
4.2.20
Novozymes
4.2.21
Organ Recovery Systems
4.2.22
Orquest
4.2.23
Ortheon Medical
4.2.24
Orthologic Corp.
4.2.25
Orthovita, Inc.
4.2.26
Osiris Therapeutics, Inc.
4.2.27
Osteobiologics
4.2.28
Regen Biologics, Inc.
4.2.29
Regeneration Technologies
4.2.30 TEI
BioSciences
4.2.31
Tutogen Medical
4.2.32
Verigen
4.2.33
Zimmer
Exhibit ES-1: U.S.
2002(E) Musculoskeletal Market Size by Segment
Exhibit ES-2:
Arthroscopy & Soft Tissue Repair Revenues Distribution 2002(E)
Exhibit ES-3: U.S.
Forecast Arthritis and Soft Tissue Population
Exhibit ES-4:
Distribution of Soft Tissue Injuries by Age Category
Exhibit ES-5:
Demographics of Age Group 18-59 as % of US Population
Exhibit ES-6:
Therapeutic Trends in Arthroscopy
Exhibit ES-8: Top 10
in U.S. Market Share in Arthroscopy & Soft Tissue Repair
Exhibit ES-9: Market
Leaders Product Focus
Exhibit ES-10:
Projected Product Mix: Soft Tissue Repair Devices vs. Orthobiologics
Exhibit ES-11:
Companies Developing Orthobiologic Technologies
Exhibit ES-12: hMSCs
Differentiation Process
Exhibit 1-1:
Demographics of Arthritis in U.S. Population (n=32,000)
Exhibit 1-2: Chondryl
Injury Classification System
Exhibit 1-3: Knee
Dislocation Classifications
Exhibit
1-4:
Meniscal Tear Classifications
Exhibit 1-5: Rotator
Cuff Syndrome Classifications
Exhibit 1-6: Ligament
Sprain Classifications
Exhibit 1-7: PCL Tear
Grading
Exhibit 1-8: Major
Causes of The Most Common Tendon Rupture
Exhibit 1-9: Common
Causes of Bursitis of the Shoulder and Knee
Exhibit 1-10:
Diagnosis & Treatment Trends in Arthroscopy
Exhibit 1-11: Effects
of Viscosupplementation
Exhibit 1-12: Rotator
Cuff Tear Configurations with Recommended Repair
Exhibit 2-1: Typical
Arthroscopic Procedure:
Exhibit 2-2:
Arthroscopic Cameras
Exhibit 2-3:
Autoclavable Cameras Potential Sterilization Savings
Exhibit 2-4: 4mm
Direct View Arthroscopes
Exhibit 2-5: Powered
Light Source
Exhibit 2-6:
Arthroscopic Application Electrosurgical Devices
Exhibit
2-7:
Suture Management Instrumentation
Exhibit 2-8:
Comparison of Screw Implants
Exhibit 2-9: Suture
Anchor Products
Exhibit 2-10: Mini
Anchors Comparison by Minor Diameter
Exhibit 2-11:
Comparison of Meniscus Repair Devices
Exhibit 2-12:
Comparison of Pullout Force of Meniscus Repair Devices
Exhibit 2-13: Sources
of Allograft for Knee Soft Tissue Repair
Exhibit 2-14:
Complications from Arthroscopic Procedures
Exhibit 2-15:
Resorbable Shoulder Repair Products
Exhibit 2-16:
Resorbable Meniscus Repair Products
Exhibit 2-17:
Resorbable Ligament Repair Products
Exhibit 2-18: hMSCs
Differentiation Process
Exhibit 2-19: MACI
Success Rate
Exhibit 2-20: Collagen
Types
Exhibit
2-21:
Comparison of the Molecular Weights of Naturally Occurring and Commercially
Available Viscosupplements
Exhibit 2-22:
Comparison of HA Products by Dosage
Exhibit 2-23: U.S.
Pending Approval HA Products
Exhibit 3-1:
Demographics of Age Group 18-59 as % of US Population
Exhibit 3-2:
Technology Mix in Soft Tissue Repair Market
Exhibit 3-3:
Arthroscopy & Soft Tissue Repair Revenues Distribution
Exhibit 3-4:
Arthroscopic Knee & Shoulder Procedural Volumes
Exhibit 3-5: Product
Segmentation by Life Cycle
Exhibit 3-6: U.S.
Arthroscopic Equipment Forecast
Exhibit 3-7: U.S.
Procedure Specific Device Forecast
Exhibit 3-8: ASP
Meniscus Repair Product
Exhibit 3-9: ASP
Ligament Repair Products
Exhibit 3-10: ASP
Anchor Repair Products
Exhibit 3-11:
Orthobiologic Forecast
Exhibit 3-12:: Top 10
in U.S. Market Share in Arthroscopy & Soft Tissue Repair
Exhibit 3-13:
Market Leaders Product Focus
|
